ArticleInternational journal of molecular sciences2026
Identification of a Novel Placental Peptide with Skin Reparative Properties by Cell-Surface Affinity Screening.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Placental extracts are rich in bioactive molecules and exhibit broad reparative properties, yet the molecular constituents responsible for their effects on skin tissue repair remain insufficiently characterized. In this study, we employed a cell-surface affinity-based screening approach using dermal fibroblasts (BJ) and microvascular endothelial (HMEC-1) cells as dual biological baits to capture bioactive peptides directly from placental extracts. Through liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis and background subtraction, a peptide with dual-cell targeting potential, GPPVSE, was identified. In vitro, GPPVSE significantly promoted the viability, proliferation and migration of both BJ and HMEC-1 cells and enhanced endothelial tube formation. In vivo, topical 20 μM GPPVSE in a mouse full-thickness skin defect model achieved an 84.7% wound closure rate by day 8, outperforming both phosphate-buffered saline (PBS) and epidermal growth factor (EGF) groups. Histological analysis revealed that GPPVSE promoted granulation tissue maturation, strengthened epidermal-dermal junction integrity, and enhanced regeneration of skin appendages, including hair follicles and sebaceous glands, during the remodeling phase. Collectively, GPPVSE provides valuable molecular insights into the reparative activity of placental extracts and establishes a potentially adaptable cell-based paradigm for mining functional peptides from complex natural sources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.